Nature Communications · 2019 · 119 citations · 37 references
MedicineBioengineeringOncologyPrecision OncologyTranslational OncologyTumor PathologyBiomedical InstrumentationBlood CollectionCirculating Tumor CellsTumor MarkersCanine ModelsCirculating Tumor BiomarkersCirculating Tumor Cell BiomarkersCirculating Tumor Cell EnumerationEnrichmentIntra-tumor Heterogeneity
Circulating tumor cells (CTCs) have become an established biomarker for prognosis in patients with various carcinomas. However, current ex vivo CTC isolation technologies rely on small blood volumes from a single venipuncture limiting the number of captured CTCs. This produces statistical variability and inaccurate reflection of tumor cell heterogeneity. Here, we describe an in vivo indwelling intravascular aphaeretic CTC isolation system to continuously collect CTCs directly from a peripheral vein. The system returns the remaining blood products after CTC enrichment, permitting interrogation of larger blood volumes than classic phlebotomy specimens over a prolonged period of time. The system is validated in canine models showing capability to screen 1-2% of the entire blood over 2 h. Our result shows substantial increase in CTC capture, compared with serial blood draws. This technology could potentially be used to analyze large number of CTCs to facilitate translation of analytical information into future clinical decisions.
37
Isolation of rare circulating tumour cells in cancer patients by microchip technology
Sunitha Nagrath, Lecia V. Sequist, Shyamala Maheswaran et al. · Nature · 2007 · 3.5K citations · Full text
Medicine, Cancer Biology, Oncology +15
Steven J. Cohen, Cornelis J.A. Punt, Nicholas Iannotti et al. · Journal of Clinical Oncology · 2008 · 1.8K citations · Full text